Press Releases

Press Releases

Date Title and Summary Additional Formats
Toggle Summary ZIOPHARM Oncology to Present at C.E. Unterberg, Towbin Life Sciences Conference View HTML
Toggle Summary ZIOPHARM Oncology to Present at Bio Investor Forum View HTML
Toggle Summary ZIOPHARM Oncology, Inc. Announces Symbol Change to ZIOP
ZIOPHARM Oncology, Inc. Announces Symbol Change to ZIOP New York, NY - September 26, 2005 - ZIOPHARM Oncology, Inc. (OTC BB: ZIOP) announced today its ticker symbol has changed from "ESWB" to "ZIOP". The symbol change, which is effective as of the opening of business today, is a result of the
View HTML
Toggle Summary ZIOPHARM, Inc. and EasyWeb, Inc. Merge to Form ZIOPHARM Oncology, Inc. View HTML
Toggle Summary ZIOPHARM Completes $18 Million Financing View HTML
Toggle Summary ZIOPHARM Starts Phase I Study of ZIO-101
Solid Tumor Study Underway at M. D. Anderson
View HTML
Toggle Summary ZIOPHARM Starts Phase I Study of ZIO-101
ZIOPHARM Starts Phase I Study of ZIO-101 CHARLESTOWN, MA May 19, 2005 - ZIOPHARM, Inc. announced dosing of the first patient in its phase I study of the safety and dosing of ZIO-101, the Company's proprietary small molecule organic arsenic. The study, in up to 40 patients with diverse blood and
View HTML
Toggle Summary ZIOPHARM Presents ZIO-201 Preclinical Data At AACR
Phase I Clinical Trial Ongoing
View HTML
Toggle Summary ZIOPHARM Announces Approval of IND for ZIO-101
Phase I trial in cancer to begin this month
View HTML
Toggle Summary ZIOPHARM Initiates Collaborative Research Agreement with Southern Research Institute
Option on Novel IPM Analogs
View HTML